Transfusion medicine illustrated. Profound piperacillin-mediated drug-induced immune hemolysis in a patient with cystic fibrosis.
Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee 37232, USA.
Eric
E
Gehrie
Anne T
AT
Neff
Kristen K
KK
Ciombor
Nadine
N
Harris
Adam C
AC
Seegmiller
Pampee P
PP
Young
D000900:Anti-Bacterial Agents / Q000009:adverse effects* / Q000627:therapeutic use; D003550:Cystic Fibrosis / Q000097:blood*; D005260:Female; D006454:Hemoglobins; D006461:Hemolysis / Q000187:drug effects*; D006801:Humans; D010878:Piperacillin / Q000009:adverse effects* / Q000627:therapeutic use; D011014:Pneumonia / Q000097:blood / Q000188:drug therapy; D011552:Pseudomonas Infections / Q000188:drug therapy; D011550:Pseudomonas aeruginosa; D055815:Young Adult
D000900:Anti-Bacterial Agents; D006454:Hemoglobins; D010878:Piperacillin